| Dr Carrie A Bennett, DNP, RN, GCNS-BC | |
|
202 S Park St, Madison, WI 53715-1507 | |
| (608) 417-5724 | |
| Not Available |
| Full Name | Dr Carrie A Bennett |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Gerontology |
| Location | 202 S Park St, Madison, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831794650 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SG0600X | Clinical Nurse Specialist - Gerontology | 134029-30 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carrie A Bennett, DNP, RN, GCNS-BC 202 S Park St, Madison, WI 53715-1507 Ph: (608) 417-5724 | Dr Carrie A Bennett, DNP, RN, GCNS-BC 202 S Park St, Madison, WI 53715-1507 Ph: (608) 417-5724 |
News Archive
Researchers have found a new oncogenic signaling pathway by which the environmental toxin arsenic may lead to adverse health effects, including bladder cancer. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.
A study from Emory University School of Medicine published in the Journal of the American Medical Association has found that severe anemia, but not red blood cell transfusions (RBC), is associated with an increased risk for a potentially fatal intestinal condition in premature infants.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.
Research led by Suresh Alahari, PhD, Professor of Biochemistry and Molecular Biology at LSU Health New Orleans School of Medicine, has shown for the first time that a tiny piece of RNA deregulates energy metabolism, an emerging hallmark of cancer. The finding identifies a new target for therapeutic intervention in breast cancer.
Mirna Therapeutics, Inc. announced today that the USPTO has allowed claims related to the therapeutic application of let-7 in the regulation of oncogenes. The claims derive from a patent application that was submitted by Yale University and exclusively licensed to Mirna related to the pioneering work of Dr. Frank Slack, Professor of Molecular, Cellular & Developmental Biology at Yale University in New Haven, CT.
› Verified 6 days ago
Connie Sue Mccullick, APNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Madison, WI 53715 Phone: 608-251-6100 Fax: 608-260-2951 | |
Ms. Mary A Vassalotti, APNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6625 Fax: 608-417-5934 | |
Susan Tuomi Cornwell, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 451 Junction Road, Madison, WI 53717 Phone: 608-263-6420 Fax: 608-265-8065 | |
Joseph W Liggett Jr., Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6993 | |
Deborah K Hummel, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 20 S Park St, Madison, WI 53715 Phone: 608-287-2770 | |
Nicole Foytik, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 202 S Park St, Madison, WI 53715 Phone: 608-417-6523 | |
Andrea Stapelman, RN, ACCNS- AG Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-8812 |